Literature DB >> 8777279

Risk factors for expression and progression of limited joint mobility in insulin-dependent childhood diabetes.

J Vuković1, M Dumić, A Radica, B Filipović-Grcić, V Jovanović.   

Abstract

We studied the prevalence of limited joint mobility (LJM) in 100 diabetic children and 100 non-diabetic controls. Our objective was to find possible predictors for the expression and progression of LJM and to evaluate the relationship between LJM and other long-term complications of insulin-dependent diabetes mellitus. LJM was present in 36% of diabetic patients aged 2-20 years. It was significantly related to duration of disease and longitudinal glycated haemoglobin (HbA1c) concentrations, pubertal stage, number of ketoacidosis and skin changes. Fourteen patients had peripheral neuropathy, 16 had microalbuminuria, 8 had nephropathy, and 7 had retinopathy. After matching for duration of disease, HbA1c concentrations and pubertal stage, a comparison of the complication rates was made. All long-term complications were significantly associated with LJM. Longer duration of disease and higher mean longitudinal glycated haemoglobin level are independent predictors for expression of LJM. Thus, improvement of metabolic control in diabetic patients before puberty may diminish the expression and progression of LJM.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8777279     DOI: 10.1007/bf00571934

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  21 in total

Review 1.  Non-enzymatic glycosylation.

Authors:  L Kennedy; T J Lyons
Journal:  Br Med Bull       Date:  1989-01       Impact factor: 4.291

2.  A simple method for routine measurement of glycosylated haemoglobin.

Authors:  M Nikolov; L Damianova
Journal:  Diabetologia       Date:  1983-05       Impact factor: 10.122

3.  Joint contracture--common manifestation of childhood diabetes mellitus.

Authors:  A Grgic; A L Rosenbloom; F T Weber; B Giordano; J I Malone; J J Shuster
Journal:  J Pediatr       Date:  1976-04       Impact factor: 4.406

4.  The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests.

Authors:  P J Dyck; K M Kratz; K A Lehman; J L Karnes; L J Melton; P C O'Brien; W J Litchy; A J Windebank; B E Smith; P A Low
Journal:  Neurology       Date:  1991-06       Impact factor: 9.910

Review 5.  Limited joint mobility in insulin dependent childhood diabetes.

Authors:  A L Rosenbloom
Journal:  Eur J Pediatr       Date:  1990-03       Impact factor: 3.183

6.  Age-related normalization of the browning rate of collagen in diabetic subjects without retinopathy.

Authors:  V M Monnier; C A Elmets; K E Frank; V Vishwanath; T Yamashita
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

7.  Limited joint mobility in subjects with insulin dependent diabetes mellitus: relationship with eye and kidney complications.

Authors:  S K Garg; H P Chase; G Marshall; W E Jackson; D Holmes; S Hoops; S Harris
Journal:  Arch Dis Child       Date:  1992-01       Impact factor: 3.791

8.  Alterations in the pulsatile properties of circulating growth hormone concentrations during puberty in boys.

Authors:  P M Martha; A D Rogol; J D Veldhuis; J R Kerrigan; D W Goodman; R M Blizzard
Journal:  J Clin Endocrinol Metab       Date:  1989-09       Impact factor: 5.958

9.  Limited joint mobility of the hand in type I diabetes mellitus.

Authors:  H Starkman; S Brink
Journal:  Diabetes Care       Date:  1982 Sep-Oct       Impact factor: 19.112

10.  Skin, joint, and pulmonary changes in type I diabetes mellitus.

Authors:  B Buckingham; A J Perejda; C Sandborg; A K Kershnar; J Uitto
Journal:  Am J Dis Child       Date:  1986-05
View more
  1 in total

1.  Longitudinal relation between limited joint mobility, height, insulin-like growth factor 1 levels, and risk of developing microalbuminuria: the Oxford Regional Prospective Study.

Authors:  R Amin; T K Bahu; B Widmer; R N Dalton; D B Dunger
Journal:  Arch Dis Child       Date:  2005-10       Impact factor: 3.791

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.